Predrag Sikirics group (School of Medicine, University of Zagreb, 1991 ) Most common experimental dose in animal studies: 10 g/kg intraperitoneally or per os, daily Standard targeted pathways: VEGFR2 angiogenesis, NO synthase , 5-HT2A serotonin receptor, dopamine D2 receptor Clinical program in Croatia halted at Phase 2 (Crohns disease) WADA Prohibited List: added in 2022 to category S0 (Non-Approved Substances) Reference sources (PubMed) Sikiric P
its about understanding the why behind the protocol
Structural and Functional Comparison of GHK-Cu and AHK-Cu Molecular Structure GHK-Cu and AHK-Cu share similarities in their overall structure, but the substitution of glycine with alanine in AHK-Cu creates significant differences
What makes it interesting isnt just the gut connection
How does 5-Amino-1MQ reconstitution compare to other peptides like BPC-157 or TB-500
This dual preservation of both NAD+ and methylation resources represents a unique mechanism among metabolic modulators, positioning 5-amino-1MQ as a bridge between energy metabolism and epigenetic regulation